Kips Bay Medical Announces the First eSVS® Mesh Implant by the Emory University Cardiothoracic Clinical Research Unit

Published: Sep 18, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MINNEAPOLIS--(BUSINESS WIRE)--Manny Villafaña, Chairman and CEO of Kips Bay Medical Inc. (NASDAQ:KIPS), announced that on September 4, 2013, the Emory Heart & Vascular Center in Atlanta, Georgia, performed its first implant of an eSVS® Mesh. This implant was performed as part of the Kips Bay Medical eMESH I clinical feasibility trial currently being conducted for the U.S. Food and Drug Administration (FDA) in a number of preeminent cardiac surgery centers in both Europe and the United States.

Help employers find you! Check out all the jobs and post your resume.

Back to news